Anest. intenziv. Med. 2009;20(1):3-4

Invazivní kandidózy - změna léčebného paradigmatu?Editorial

Pavel Ševčík
Klinika anesteziologie, resuscitace a intenzivní medicíny LF Masarykovy univerzity Brno a Fakultní nemocnice Brno

Published: February 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ševčík P. Invazivní kandidózy - změna léčebného paradigmatu? Anest. intenziv. Med. 2009;20(1):3-4.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pfaller, M. A., Diekema, D. J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Review, 2007, 20, p. 133-163. Go to original source... Go to PubMed...
    2. Martin, G. S., Mannino D. M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med., 2003, 348, p. 1546-1554. Go to original source... Go to PubMed...
    3. Pappas, P. G., Rex, J. H., Sobel, J. D. et al. Guidelines for treatment of candidiasis. IDSA Guidelines. Clin. Infect. Dis., 2004, 38, p. 161-189. Go to original source... Go to PubMed...
    4. Wisplinghoff, H., Bischoff, T., Tallent S. M., Seifert H. et al. Nosocomial bloodstream infections in US hospitals: analysis of 24.179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis., 2004, 39, p. 309-317. Go to original source... Go to PubMed...
    5. Wenzel, R. P., Gennings, C. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin. Infect. Dis., 2005, 41, Suppl. 6, p. S389-S393. Go to original source... Go to PubMed...
    6. Almirante, B., Rodriguez, D., Park, B. J. et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol, 2005, 43, p. 1829-1835. Go to original source... Go to PubMed...
    7. Diekema, D. J., Pfaller, M. A. Nosocomial candidemia: an ounce of prevention is better than a pound of cure. Infect. Control Hosp. Epidemiol., 2004, 25, p. 624-626. Go to original source... Go to PubMed...
    8. Fridkin, S. K. Candidemia is costly - plain and simple. Clin. Infect. Dis., 2005, 41, p. 1240-1241. Go to original source... Go to PubMed...
    9. Morrell, M., Fraser, V. J., Kollef, M. J. Delaying empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for mortality. Antimicrob. Agents Chemother., 2005, 49, p. 3640-3645. Go to original source... Go to PubMed...
    10. Garrouste-Orgeas, M., Timsit, J. F., Tafflet M. et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin. Infect. Dis., 2006, 42, p. 1118-1126. Go to original source... Go to PubMed...
    11. Alexander, B. D., Pfaller, M. A. Contemporary tools for the diagnosis and management of invasive mycoses. Clin. Infect. Dis., 2006, 43, p. S15-S27. Go to original source...
    12. Ostrosky-Zeichner, L., Pappas, P. G. Invasive candidiasis in the intensive care unit. Crit. Care Med., 2006, 34, p. 857-863. Go to original source... Go to PubMed...
    13. Charles, P. E. Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection? Crit. Care Med., 2006, 34, p. 913-914. Go to original source... Go to PubMed...
    14. Ostrosky-Zeichner, L. Prophylaxis and treatment of invasive candidiasis in the intensive care setting. Eur. J. Clin. Microbiol. Infect. Dis., 2004, 23, p. 739-744. Go to original source... Go to PubMed...
    15. Sobel, J. D., Rex, J. H. Invasive candidiasis: turning risk into a practical prevention policy. Clin. Infect. Dis., 2001, 33, p. 187-190. Go to original source... Go to PubMed...
    16. Haber, J., Ráčil, Z., Mayer, J. et al. Léčba invazivní kandidózy - doporučení odborných společností. Anest. intenziv. Med., 2009, 20, č. 1, s. 37-47.
    17. Pappas, P. G. et al. Dostupné na: www.idsociety.org/Work Area/downloadasset.aspx?id=7818
    18. Puzniak, L., Teutsch S., Powderly W., Polish, L. Has the epidemiology of nosocomial candidemia changed? Infect. Control Hosp. Epidemiol., 2004, 25, p. 628-633. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.